Return to Publications  |  Return to CINJ Home
The Cancer Institute of New Jersey's Cancer Connection, August 2013

Your link to the latest news on research, treatment, prevention and education from the state's only

National Cancer Institute-designated Comprehensive Cancer Center

 

 

$2M Grant Awarded for Development of Tumor Identification Tools

 

Foran

David J. Foran, PhD, chief informatics officer and executive director of biomedical informatics at Rutgers Cancer Institute of New Jersey, has been awarded a $2 million competitive renewal grant from the National Institutes of Health to expand work on developing computational tools for classifying different types of cancers. The focus is to design, develop and implement state-of-the-art imaging and computational tools for characterizing cancers of the breast, head and neck, ovaries, prostate and skin.Learn more

Shut Down of Cell Survival Process Influences Fate of Lung Cancer Tumors

 

White

Research from Rutgers Cancer Institute of New Jersey, Princeton University and other collaborators suggests that inactivation of an essential gene responsible for the cell survival process known as autophagy can suppress the growth of non-small-cell lung cancer tumors and render them more benign. The findings published in the July edition of Genes & Development suggest a possible role for autophagy blockers in the treatment of this type of lung cancer, which has a 5-year survival rate of only 30 to 50 percent for early-stage diseases.Learn more

Free Prostate Cancer Screenings

 

prostate screening

Registration is now open for the annual Prostate Cancer Screening/Education Event sponsored by Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital. This year's event will be held September 23, 24 and 25 from 5pm to 8pm each night at the Cancer Institute. The screenings - open to men 40 and older - are free, but registration is necessary. To register, call 1-888-MD-RWJUH (1-888-637-9584).Learn more

New Physicians Join Rutgers Cancer Institute of New Jersey

 

new physicians

Jocelyn Lewis, DO, a pediatric hematologist/oncologist recently joined Rutgers Cancer Institute of New Jersey from St. Jude Children's Research Hospital, having served as both a staff physician in the Solid Tumor Division and oncology hospitalist in the Department of Oncology and Bone Marrow Transplantation. She completed a fellowship in pediatric hematology/oncology at the Medical University of South Carolina, which was preceded by a residency in pediatric medicine at the University of Maryland. As part of the Pediatric Hematology/Oncology Program at the Cancer Institute, Dr. Lewis will help evaluate and manage the care of those pediatric patients with solid tumors. Vadim Koshenkov, MD, recently joined the Cancer Institute's Surgical Oncology Division after having completed a surgical oncology fellowship at the University of Miami. This was preceded by a general surgery residency at Morristown Medical Center (Morristown, New Jersey). Dr. Koshenkov will provide surgical evaluation and services to those patients seen within the Melanoma and Soft Tissue Oncology Program at the Cancer Institute.

Rutgers Cancer Institute of New Jersey Nurse Honored as NJBIZ Healthcare Hero

 

Beth Savage

Beth Savage, RN, MSN, CPNP, a pediatric nurse practitioner at Rutgers Cancer Institute of New Jersey, was recently honored as a finalist for 'Nurse of the Year' in the 2013 NJBIZ Healthcare Heroes awards program. Savage provides care to patients with cancer and varied blood disorders in the Pediatric Hematology/Oncology Program at the Cancer Institute. She has expertise not only in treating patients with sickle cell disease, but also in educating families and other nursing professionals about the condition.Learn more

            Rutgers Cancer Institute of New Jersey                                          NCI logo 

Office of Communications         ·         www.cinj.org        ·        732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List